Mulpleta
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $155,602 | 886 | 712 |
| 2019 | $444,305 | 6,183 | 2,825 |
| 2018 | $154,780 | 406 | 292 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $235,250 | 54 | 31.2% |
| Consulting Fee | $218,623 | 130 | 29.0% |
| Food and Beverage | $146,698 | 7,037 | 19.4% |
| Unspecified | $57,140 | 38 | 7.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,210 | 17 | 5.2% |
| Space rental or facility fees (teaching hospital only) | $38,650 | 17 | 5.1% |
| Travel and Lodging | $14,773 | 50 | 2.0% |
| Education | $2,333 | 131 | 0.3% |
| Grant | $2,011 | 1 | 0.3% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures L-PLUS 2 | Shionogi Inc | $57,140 | 0 |
Top Doctors Receiving Payments for Mulpleta
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Antonio, TX | $97,801 | 56 |
| , MD | Internal Medicine | San Antonio, TX | $84,802 | 50 |
| , MD | Hepatology | New York, NY | $36,792 | 21 |
| , M.D | Hepatology | Boston, MA | $27,154 | 14 |
| , MD | Gastroenterology | Cleveland, OH | $25,359 | 24 |
| , M.D | Gastroenterology | Norwood, OH | $17,900 | 14 |
| , MD | Transplant Surgery | Los Angeles, CA | $17,002 | 8 |
| , M.D | Hepatology | Fort Worth, TX | $15,796 | 19 |
| , M.D | Internal Medicine | Largo, FL | $14,516 | 15 |
| , MD | Hepatology | Dallas, TX | $13,792 | 11 |
| Victor Ankoma-Sey | — | Houston, TX | $13,072 | 25 |
| , MD | Gastroenterology | Chicago, IL | $12,465 | 8 |
| , MD | Gastroenterology | Rocky Mount, NC | $12,343 | 8 |
| , M.D | Gastroenterology | La Jolla, CA | $9,376 | 14 |
| , M.D | Hepatology | Chula Vista, CA | $9,307 | 10 |
| , M.D | Internal Medicine | Flushing, NY | $9,168 | 14 |
| , MD | Gastroenterology | Newport News, VA | $8,820 | 7 |
| , M.D | Internal Medicine | New Orleans, LA | $8,115 | 8 |
| , MD | Transplant Hepatology | Memphis, TN | $7,817 | 4 |
| , MD | Transplant Hepatology | Philadelphia, PA | $7,806 | 7 |
| , DO | Gastroenterology | San Antonio, TX | $7,672 | 12 |
| , DO | Gastroenterology | Allentown, PA | $7,271 | 6 |
| , M.D | Gastroenterology | Stanford, CA | $7,232 | 6 |
| , M.D | Gastroenterology | Clifton, NJ | $6,000 | 8 |
| , M.D | Gastroenterology | Colorado Spgs, CO | $5,984 | 11 |
Manufacturing Companies
- Shionogi Inc $754,687
Product Information
- Type Drug
- Total Payments $754,687
- Total Doctors 3,150
- Transactions 7,475
About Mulpleta
Mulpleta is a drug associated with $754,687 in payments to 3,150 healthcare providers, recorded across 7,475 transactions in the CMS Open Payments database. The primary manufacturer is Shionogi Inc.
Payment data is available from 2018 to 2020. In 2020, $155,602 was paid across 886 transactions to 712 doctors.
The most common payment nature for Mulpleta is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($235,250, 31.2% of total).
Mulpleta is associated with 1 research study, including "Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures L-PLUS 2" ($57,140).